-
News | 2016.03.15
Zika and microcephaly: first trimester of pregnancy most critical
A new analysis of data from the 2013-2014 Zika epidemic in French Polynesia by scientists from the Institut Pasteur, Paris, and their French Polynesian colleagues has confirmed the incidence of grouped cases of microcephaly and quantified the risk of microcephaly associated with the virus. Using innovative mathematical modeling techniques, their research shows that the risk of microcephaly is...
-
News | 2016.03.20
A genomic study of epidemic dysentery: how Europe exported a scourge worldwide
Scientists at the Institut Pasteur and its International Network, the Wellcome Trust Sanger Institute (Cambridge, United Kingdom) and several international institutions have just published an exceptionally wide-ranging study tracing the history of the bacillus responsible for epidemic dysentery – one of the worst scourges to afflict humans throughout the 18th and 19th centuries. This vast...
-
News | 2016.03.22
Lluis Quintana-Murci appointed as Scientific Director of the Institut Pasteur
On March 23, the Institut Pasteur announced that Lluis Quintana-Murci had been appointed as Scientific Director. This new position has been created in connection with the implementation of the general strategic plan adopted by the Institut Pasteur management. Lluis Quintana-Murci, a member of the Executive Board, will serve as the person of reference and coordinator for the Institut Pasteur's...
-
News | 2016.04.10
Malaria: a new route of access to the heart of the parasite
Scientists have just identified an Achilles heel in the parasite that causes malaria, by showing that its optimum development is dependent on its ability to expropriate RNA molecules in infected cells – a host-pathogen interaction that had never previously been observed.
-
News | 2016.04.24
How could Zika enter Europe?
Researchers at the Institut Pasteur have assessed the transmission potential of four populations of Aedes mosquitoes in circulation on the island of Madeira and southern France with a view to examining various possible scenarios for the introduction of Zika virus to Europe. Their work suggests that the Aedes aegypti mosquito present in Madeira is more likely to promote local transmission of Zika...
-
News | 2016.05.11
Meningococcal disease: identification of a sexually transmitted variant
A study from the University of Würzburg (Germany) and the Institut Pasteur (France) elucidates the mechanisms of the emergence of an outbreak of meningococcal disease in men who have sex with men (MSM). These results are published in the open access journal PLOS ONE.
-
News | 2016.05.11
The Institut Pasteur signs Framework-Agreement with the Centre National d’Etude Spatiale
On Monday 9th Mai, 2016 on the Institut Pasteur campus, the President of the Institut Pasteur, Christian Bréchot and the President of the French space agency (CNES), Jean-Yves Le Gall signed a 5-year Framework Agreement.
-
News | 2016.05.17
HIV: Identification of key immune response receptors in patients spontaneously controlling infection
A small number of patients infected by HIV spontaneously control viral replication without antiretroviral therapy, and do not develop the disease. The ability of these rare patients, known as "HIV controllers", to suppress HIV replication appears to be down to a highly effective immune response. Scientists observed that CD4+ T immune cells in these patients were capable of recognizing...
-
News | 2016.06.05
Identification of a therapeutic compound for a genetic form of autism spectrum disorders thanks to high throughput screening
A team of researchers has highlighted the therapeutic potential of lithium in a patient with a rare form of autism spectrum disorder associated with SHANK3 gene mutation. This molecule, usually used to treat bipolar disorder, was identified thanks to high throughput screening of chemical compounds on human neurons derived from pluripotent stem cells, including those of the treated patient.
-
News | 2016.06.22
Malaria - First global mapping of artemisinin resistance confirms definitively that resistance is confined to Southeast Asia and has not spread to sub-Saharan Africa
The first global mapping of artemisinin resistance (the KARMA study) has definitively confirmed that resistance to the main drug currently used in the treatment of Plasmodium falciparum malaria is for the moment confined to Southeast Asia and has not spread to sub–Saharan Africa.
